Объявление размещено на обновляемом сайте
Форма для участия: http://www.karolinska.se/templates/Page____73929.aspx?epslanguage=EN
Предварительная программа: http://www.karolinska.se/templates/Page____73910.aspx?epslanguage=EN
For the second time, on behalf of the European Association of Clinical Pharmacology and Therapeutics (EACPT) and in collaboration with EMEA, the Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital, Stockholm, arranges the course:
principles and practice
The course will take place in Stockholm, Sweden, April 7 – 11, 2008
and starts on Monday April 7 at 13:00 (1 pm). It ends at 12:00 (noon) on Friday April 11.
The course is directed to clinical pharmacologists, other clinical specialist or health care professionals engaged in clinical, regulatory, scientific or public health oriented aspects of adverse drug reactions and drug safety.
The course will be held at the Division of Clinical Pharmacology, Karolinska University Hospital (Huddinge), located some 20 km south of Stockholm.
One day will be spent in Uppsala at the Medical Products Agency and the WHO Collaborating Centre for International Drug Monitoring (UMC- the Uppsala Monitoring Centre)
Included in the course fee is:
Full curriculum and documentation, beverages during breaks and lunches.
Local public transportation including travel between Stockholm and Uppsala.
Travel expenses to Stockholm, per diem, insurances, as well as accommodation is paid by the participant. Tours and excursions are not included. Information about suitable accommodation (hotels with special rates for Karolinska Institutet course participants available on a first come basis) will be sent with the application for. For further information, please contact Ms Sissi Myllyniemi.
Course fee (reduced fee before March 1, 2008)
€ 650 Academic affiliation or governmental employment
€ 950 Employees of the commercial sector
The Application Form will be provided to anyone that announces his/her interest by sending an E-mail or message to Ms Sissi Myllyniemi
email@example.com Fax: +46 8 585 810 50
Participants will be accepted on a first come basis. The 2005 course was completely signed up.
Anders.Rane@ki.se Professor & Chairman/Course leader
Ulf.Bergman@karolinska.se Professor/Director of studies
Karolinska Institutet, Division of Clinical Pharmacology, SE-141 86 Stockholm, Sweden